The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
A collection of functions dedicated to simulating staggered entry platform trials whereby the treatment under investigation is a combination of two active compounds. In order to obtain approval for this combination therapy, superiority of the combination over the two active compounds and superiority of the two active compounds over placebo need to be demonstrated. A more detailed description of the design can be found in Meyer et al. <doi:10.1002/pst.2194> and a manual in Meyer et al. <doi:10.48550/arXiv.2202.02182>.
Version: | 1.0.5 |
Depends: | R (≥ 3.5.0) |
Imports: | dplyr, purrr, ggplot2, plotly, tidyr, parallel, doParallel, foreach, openxlsx, forcats, epitools, zoo |
Suggests: | knitr, rmarkdown, DT, gtools |
Published: | 2022-02-14 |
DOI: | 10.32614/CRAN.package.CohortPlat |
Author: | Elias Laurin Meyer [aut, cre], Peter Mesenbrink [ctb], Cornelia Dunger-Baldauf [ctb], Ekkehard Glimm [ctb], Franz Koenig [ctb] |
Maintainer: | Elias Laurin Meyer <elias.meyer at meduniwien.ac.at> |
License: | MIT + file LICENSE |
NeedsCompilation: | no |
Materials: | README |
CRAN checks: | CohortPlat results |
Reference manual: | CohortPlat.pdf |
Vignettes: |
CohortPlat |
Package source: | CohortPlat_1.0.5.tar.gz |
Windows binaries: | r-devel: CohortPlat_1.0.5.zip, r-release: CohortPlat_1.0.5.zip, r-oldrel: CohortPlat_1.0.5.zip |
macOS binaries: | r-release (arm64): CohortPlat_1.0.5.tgz, r-oldrel (arm64): CohortPlat_1.0.5.tgz, r-release (x86_64): CohortPlat_1.0.5.tgz, r-oldrel (x86_64): CohortPlat_1.0.5.tgz |
Old sources: | CohortPlat archive |
Please use the canonical form https://CRAN.R-project.org/package=CohortPlat to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.